目的：研究普瑞搏思对糖尿病胃肠道功能紊乱的治疗作用．方法：采用放射性核素99mTc。标记试餐，计算机断层摄影（SPECT）显像技术检测107例糖尿病患者的胃半排空时间（T1/2），同时检测空腹血糖．结果：47例患者（43．9％）胃T1／2延迟，将以上47例患者随机分为二组：A组24例，降糖药加普瑞搏思30mg／d；B组23例，单用降糖药．二组疗程均为1个月．A组有效来为91．6％，B组均无效。比较对胄轻瘫、血糖的疗效，A组优于B组．结论：糖尿病性胃轻瘫与高血糖相关．普瑞搏思是有力的促进胄动力的药物，对糖尿病性胄轻瘫有一定的疗效． Objective: To study the therapeutic effect of Purifacs on diabetic gastrointestinal disorders. Methods: Radionuclide 99mTc was used. The test meal and computerized tomography (SPECT) imaging technique were used to detect the gastric emptying time (T1 / 2) in 107 diabetic patients and the fasting blood glucose was measured. Results: Twenty-seven patients (43.9%) had delayed gastric T1 / 2. The above 47 patients were randomly divided into two groups: A group (24 cases), hypoglycemic agent Hypoglycemic agents alone. Two groups of treatment are 1 month. A group was effective to 91.6%, B group were invalid. Compared to the pituitary paraplegia, blood glucose, A group is better than the B group. Conclusion: Diabetic gastroparesis is associated with hyperglycemia. Purui Bisco is a powerful drug that boosts power and has some effect on diabetic retinopathy.